Biotech Values

[turtlepower]

ZIOP - Pretty significant dilution so I'm guessing no partnering on the horizon

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP - News) announced the pricing of its previously announced underwritten public offering of 15,484,000 shares of its common stock and warrants to purchase 7,742,000 shares of its common stock at a public offering price of $3.10 per unit. The warrants, which represent the right to acquire 0.50 of a share of the Company’s common stock for each share of common stock purchased in the offering, will have a five-year term from the date of issuance and will be exercisable at a price of $4.02 per share. JMP Securities LLC and Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News), are acting as co-lead managers for the offering.

The offering will result in gross proceeds of approximately $48.0 million and net proceeds, after deducting underwriting discounts and commissions and other estimated offering expenses are expected to be approximately $45.2 million. The offering is subject to customary closing conditions and is expected to close on Wednesday, December 9, 2009.

http://finance.yahoo.com/news/ZIOPHARM-Prices-Public-bw-1800993725.html?x=0&.v=1